poisar

Stocks · News reference

Mistras Group shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 sales guidance.

BenzingaBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncNot Specified

    MISTR to Fund 2 Million Free HIV & Hepatitis C Tests and Help States Save Hundreds of Millions in ADAP Costs

    MISTR, a telehealth platform for sexual health, announced a national commitment to provide 2 million free HIV and Hepatitis C tests by end of 2027 and introduced a partnership model to help states save hundreds of millions in AIDS Drug Assistance Program (ADAP) costs. The company will provide free PrEP to those testing negative for HIV and connect those testing positive to long-term care at no cost to patients or states.

  2. Globenewswire IncBrodsky & Smith

    BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Priority Technology Holdings, Inc. (Nasdaq – PRTH), MISTRAS Group, Inc. (NYSE – MG), The Baldwin Group, Inc. (Nasdaq – BWIN), Utz Brands, Inc. (NYSE – UTZ)

    Law firm Brodsky & Smith announced investigations into four merger transactions, examining whether company boards breached fiduciary duties by failing to conduct fair processes and pay fair value to shareholders. The investigations involve Priority Technology Holdings ($8.05/share), MISTRAS Group ($20.35/share), The Baldwin Group ($32.50/share), and Utz Brands ($14.25/share).

  3. SEC EDGARSEC EDGAR

    8-K filing — Mistras Group, Inc. (MG)

    Filed: 2026-09-18 AccNo: 0001140361-26-037107 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits